- Copyright © 2013, The American Academy of Pediatrics
Pentacel vaccine will not be available to practices until early June when supplies will continue to be limited, according to maker Sanofi Pasteur.
Sanofi updated health care providers in a March letter about the most recent shortage of Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Haemophilus b conjugate vaccine).
“Once additional doses of Pentacel vaccine are delivered in June 2013, order allocations will be reinstated until early September 2013 as we build ample inventory to begin the process of lifting order allocations in both the public and private markets,” the letter noted.
Sanofi indicated that its single-antigen diphtheria, tetanus and acellular pertussis (DTaP), inactivated polio, and Haemophilus influenza type b (Hib) vaccines remain in sufficient supply to address “historic usage of Pentacel vaccine as well as the historic demand for these single antigen vaccines.”
Meanwhile, the firm said discounts will be offered through August on orders of Pentacel, Daptacel (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed), ActHIB (Haemophilus b conjugate vaccine [tetanus toxoid conjugate] and IPOL (poliovirus vaccine inactivated). For additional information, contact your Sanofi representative or call 1-800 VACCINE (1-800-822-2463).
There are no changes in the routine immunization schedule. For information on vaccine shortages, consult the Centers for Disease Control and Prevention (CDC) web page at www.cdc.gov/vaccines/vac-gen/shortages/default.htm#1.
Find the 2013 Recommended Immunization Schedule for 0 to 18 years at http://aapnews.aappublications.org/content/34/2/17.full.pdf+html and the catch-up schedule at http://aapnews.aappublications.org/content/34/2/18.full.pdf+html.
Visit the AAP immunization web page at http://www2.aap.org/immunization/index.html.